These restrictions on the BTNX NTS are really applicable, as we identified e.g. etodesnitazene to own an analogous in vitro potency and efficacy as fentanyl [seven, thirteen] and as it could perhaps give PWUD a false sense of protection. On top of that, the detectability of nitazene analogues in drug samples might be impacted by solubility issues,